Neuroleptic Malignant Syndrome — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Neuroleptic malignant syndrome — stop the causative agent, supportive care, consider dantrolene and bromocriptine
NMS is caused by dopamine D2 receptor blockade (antipsychotics, metoclopramide, antiemetics). Features include severe rigidity ('lead pipe'), hyperthermia, altered consciousness, autonomic instability, and markedly elevated CK (rhabdomyolysis). Treatment: (1) stop the causative agent immediately, (2) aggressive supportive care (IV fluids, cooling, monitoring), (3) consider dantrolene (for rigidity/hyperthermia) and/or bromocriptine/amantadine (dopamine agonists). Mortality is ~10% if untreated. A: Serotonin syndrome has clonus and hyperreflexia (not rigidity) and is caused by serotonergic agents. C: Malignant hyperthermia occurs under general anaesthesia. D: Lethal catatonia overlaps but requires different approach. E: Thyroid storm has different precipitants.
Reference: BNF; NICE CG178 Psychosis; Boyer & Shannon Serotonin Syndrome Review